20xx年醫(yī)學(xué)專題—?dú)W洲espen關(guān)于危重癥患者的腸內(nèi)營養(yǎng)指南-在線瀏覽
2024-11-17 22:24本頁面
【正文】 e of formula Whole protein formulae are superior to the peptidebasedformulae CImmunemodulating formulae (formulae enrichedwith arginine(精氨酸 ), nucleotides（核苷酸） and w3 fatty acids) are superior to standard enteral formulae:In elective upper GI surgical patients。in patients with severe sepsis, may be harmful and are not Remended。in patients with ARDS (formulae containing o3 fatty acids and antioxidants).ABBABDue to insufficient data, no remendation support the Immunemodulating formulae apply to the burned patients, but the trace elements (Cu, Se and Zn) should besupplemented in a higher than standard doseAthe severe illness ICU patients, should not receive an immunemodulating formula enriched with arginine, nucleotides and w3 fatty acids if the EN≤700ml/d.BGlutamine should be added to standard enteralformula in burned patients and trauma patients A第五 頁 ，共二十一 頁 。 All patients （ can not be on a full oral diet within 3 days） should receive EN（C） a. It is uhical to investigate the maximum time of ICU patient can survive without nutritional support. b. Due to increased substrate metabolism（基礎(chǔ)代謝 (jīchǔ d224。)） , the critical illness is more likely to develop undernutrition. c. Scandinavian showed that the mortality rate of patient treat with glucose only 250300g/d over 14 days is 10 times higher on adequate TPN. d. so inadequate oral intake, the surgical patient is likely to develop within 8–12 days of postoperation. e. Most trials focusing the early EN or late EN after 4–6 days, have proved the positive effect of early EN, so we e to the title conclusion.第六 頁 ，共二十一 頁 。No general amount remend to be adjust EN therapy according to courseof disease. But exogenous energy supply of the acute and initial phase:≤25kcal/kg/d and recovery： ≥25kcal/kg/d may be favourable (C)a. Prospective observational cohort studyb. Ibrahimc. A recent trial ENhow much?第八 頁 ，共二十一 頁 。 Jejunal versus gastric feeding in critically illness patient
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1